Evercore downgrades Vertex; cites price and disadvantages for the franchise (NASDAQ:VRTX)
Sir Evercore ISI has downgraded Vertex Pharmaceuticals (NASDAQ:VRTX) to In Line, citing the valuation and potential hurdles for its emerging ...
Sir Evercore ISI has downgraded Vertex Pharmaceuticals (NASDAQ:VRTX) to In Line, citing the valuation and potential hurdles for its emerging ...
Vertex Pharmaceuticals (NASDAQ:VRTX) has obtained approval from the European Commission for the expanded labeling of Kaftrio (ivacaftor/tezacaftor/elexacaftor) plus ivacaftor for ...
Zolak/iStock via Getty Images Vertex Pharmaceuticals (NASDAQ:VRTX) fell ~4%marking the second straight session of losses after Leerink Partners flagged concerns ...